Naxitamab
Drug timelines are a Plus or Pro feature.
10 regulatory and trial events tracked for Naxitamab, covering 2023-09-21 to 2026-04-16. Get the full timeline:
Most recent: Clinical Trial Update: Study of Naxitamab and Sacituzumab Govitecan in Patients With Metastatic Triple-negative Breast Cancer (TNBC) [Phase 1, Phase 2]